Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (41-50 of 1,111) with videos related to

Pageof 112
Sort By:
European Heart Journal|November 4, 2021
The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethylPh Gabriel Steg, Deepak L Bhatt
The New England Journal of Medicine|March 28, 2007
Does preventive PCI work?Judith S Hochman, P Gabriel Steg
Lancet (London, England)|July 13, 2020
Differential effect of ticagrelor on irreversible harms in diabetes - Authors' replyDeepak L Bhatt, Philippe Gabriel Steg
European Heart Journal|July 13, 2007
Major bleeding after PCI. Where is our crystal ball?Frederick A Spencer, Philippe Gabriel Steg
European Heart Journal|September 29, 2004
Enoxaparin in non-ST segment elevation acute coronary syndromes: duration of therapy is essential to benefitPhilippe Gabriel Steg, Jean-Michel Juliard
Archives of Cardiovascular Diseases|March 16, 2010
Statins in the elderly: what evidence of their benefit in prevention?Ph Gabriel Steg, Claire-Marie Tissot
European Heart Journal. Acute Cardiovascular Care|October 15, 2015
Viewpoint: a proposal for a simple algorithm for managing oral anticoagulation and antiplatelet therapy in patients with non-valvular atrial fibrillation and coronary stentsPh Gabriel Steg, Deepak L Bhatt
European Heart Journal. Acute Cardiovascular Care|November 23, 2020
Chest pain triage: do genetics have a role?Jeremie Abtan, Gregory Ducrocq, Gabriel Steg
Circulation|April 4, 2018
Is There Really a Benefit to Net Clinical Benefit in Testing Antithrombotics?Philippe Gabriel Steg, Deepak L Bhatt
European Heart Journal|October 12, 2017
Identifying patients with acute total coronary occlusion in NSTEACS: finding the high-risk needle in the haystackRanil de Silva, Philippe Gabriel Steg
Pageof 112

Showing results (41-50 of 1,111) with videos related to

Sort By:
Pageof 112
European Heart Journal|November 4, 2021
The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethylPh Gabriel Steg, Deepak L Bhatt
The New England Journal of Medicine|March 28, 2007
Does preventive PCI work?Judith S Hochman, P Gabriel Steg
Lancet (London, England)|July 13, 2020
Differential effect of ticagrelor on irreversible harms in diabetes - Authors' replyDeepak L Bhatt, Philippe Gabriel Steg
European Heart Journal|July 13, 2007
Major bleeding after PCI. Where is our crystal ball?Frederick A Spencer, Philippe Gabriel Steg
European Heart Journal|September 29, 2004
Enoxaparin in non-ST segment elevation acute coronary syndromes: duration of therapy is essential to benefitPhilippe Gabriel Steg, Jean-Michel Juliard
Archives of Cardiovascular Diseases|March 16, 2010
Statins in the elderly: what evidence of their benefit in prevention?Ph Gabriel Steg, Claire-Marie Tissot
European Heart Journal. Acute Cardiovascular Care|October 15, 2015
Viewpoint: a proposal for a simple algorithm for managing oral anticoagulation and antiplatelet therapy in patients with non-valvular atrial fibrillation and coronary stentsPh Gabriel Steg, Deepak L Bhatt
European Heart Journal. Acute Cardiovascular Care|November 23, 2020
Chest pain triage: do genetics have a role?Jeremie Abtan, Gregory Ducrocq, Gabriel Steg
Circulation|April 4, 2018
Is There Really a Benefit to Net Clinical Benefit in Testing Antithrombotics?Philippe Gabriel Steg, Deepak L Bhatt
European Heart Journal|October 12, 2017
Identifying patients with acute total coronary occlusion in NSTEACS: finding the high-risk needle in the haystackRanil de Silva, Philippe Gabriel Steg
Pageof 112